Bulgaria's Sopharma reports 15% drop in Jan-Feb sales

Bulgaria's Sopharma reports 15% drop in Jan-Feb sales

Bulgarian drug maker Sopharma said on Thursday that its sales revenue fell by an annual 15% in the January-February period of 2020, due to lower sales on foreign markets.Sopharma's domestic sales decreased 2% year-on-year in the first two months of 2020, while sales abroad dropped 20%, the company said in a bourse filing.In February alone, the company's sales plunged 22%. Exports were 30% lower on the year, while domestic sales edged down 1%.The company did not disclose information about the volume of its sales or amount of sales revenue.As at 12:30 CET on Thursday, Sopharma shares traded at 0.60% higher at 3.38 levs ($1.93/1.73 euro) on the Bulgarian Stock Exchange.

Cookies Preferences
Choose Type of Cookies You Accept Using


These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.


These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.


These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.